How do I write a SOAP note for a patient with acute right calf pain and swelling suspected of deep vein thrombosis, who has recent long‑distance travel, a prior DVT, hypertension, and is on oral estrogen therapy?

SOAP Note for Calf Pain with Suspected DVT

For a patient with acute right calf pain and swelling suspected of DVT with recent long-distance travel, prior DVT, hypertension, and oral estrogen therapy, structure your SOAP note to systematically document risk stratification, diagnostic workup, and management decisions.

Subjective

Document the following specific elements:

• Chief complaint: Acute right calf pain and swelling, duration (hours/days)
• Pain characteristics: Location (localized tenderness along deep venous distribution), severity, quality (heaviness, cramping)
• Associated symptoms: Entire leg swelling vs. localized calf swelling, pitting edema confined to symptomatic leg, presence of collateral superficial veins
• Risk factors (critical for Wells score calculation 1):
  • Recent long-distance travel (immobilization >3 days equivalent)
  • Prior documented DVT (+1 point)
  • Current oral estrogen therapy (known VTE risk factor 2)
  • Hypertension (document as comorbidity)
  • Active cancer, recent surgery, or paralysis (if present)
  • Bedridden status
• Alternative diagnoses: Symptoms suggesting Baker cyst rupture, cellulitis, muscle strain, superficial thrombophlebitis

Objective

Physical examination findings to document:

• Calf circumference measurement: Measure 10 cm below tibial tuberosity; document if ≥3 cm difference from asymptomatic side (+1 point Wells score 1)
• Inspection: Entire leg swelling (+1 point), pitting edema pattern, erythema, collateral superficial veins (+1 point)
• Palpation: Localized tenderness along deep venous system (+1 point), cord-like structures
• Vital signs: Document for baseline and risk assessment

Wells Score calculation 1:

• Active cancer: 1 point
• Paralysis/paresis/recent immobilization: 1 point
• Recently bedridden ≥3 days or major surgery within 12 weeks: 1 point
• Localized tenderness along deep venous distribution: 1 point
• Entire leg swollen: 1 point
• Calf swelling ≥3 cm vs. asymptomatic side: 1 point
• Pitting edema (symptomatic leg): 1 point
• Collateral superficial veins: 1 point
• Prior documented DVT: 1 point
• Alternative diagnosis as likely: -2 points

Score interpretation: ≥2 = DVT likely; <2 = DVT unlikely 1

For this patient: Prior DVT (1) + likely additional points from examination = HIGH Wells score (likely ≥2)

Assessment

Primary diagnosis: Suspected acute right lower extremity DVT

Risk stratification:

• Wells score: [Document calculated score] - DVT likely/unlikely
• Pretest probability: High (given prior DVT, estrogen use, recent travel)
• VTE risk factors: Prior DVT (strongest predictor), oral estrogen therapy (1.5-2x increased risk 2), recent prolonged travel, hypertension

Differential diagnoses: Baker cyst rupture, cellulitis, chronic venous insufficiency, muscle strain, superficial thrombophlebitis

Plan

Diagnostic Workup

For Wells score ≥2 (DVT likely) 1, 3:

• Order complete duplex ultrasound (CDUS) from inguinal ligament to ankle including calf veins (posterior tibial, peroneal veins)
• Do NOT order D-dimer - not appropriate when pretest probability is high; proceed directly to ultrasound 1
• Ultrasound should include: compression at 2-cm intervals, spectral Doppler of common femoral veins bilaterally, popliteal spectral Doppler, color Doppler imaging 1

For Wells score <2 (DVT unlikely) 1:

• Order high-sensitivity D-dimer first
• If D-dimer negative: DVT excluded, no ultrasound needed
• If D-dimer positive: Proceed to complete duplex ultrasound

Anticoagulation Decision While Awaiting Results

Given HIGH clinical suspicion (prior DVT, multiple risk factors) 4:

• Initiate parenteral anticoagulation immediately while awaiting ultrasound results if no contraindications to anticoagulation
• Options: LMWH (enoxaparin 1 mg/kg SC q12h) or fondaparinux
• If ultrasound available within 12 hours, consider half-dose LMWH 4
• Do not start warfarin before DVT confirmed 4

If DVT Confirmed on Ultrasound

Proximal DVT (popliteal or above) 4:

• Continue anticoagulation: DOAC preferred (apixaban, rivaroxaban, edoxaban, dabigatran) over warfarin
• Discontinue oral estrogen therapy immediately - absolute contraindication with confirmed VTE
• Duration: Minimum 3 months; consider extended therapy given unprovoked nature (estrogen-provoked but with prior DVT history suggests underlying risk)

Isolated distal/calf DVT 4: Two management options based on risk factors for extension:

• Option 1 (preferred given risk factors): Anticoagulate for 3 months
  • Risk factors for extension present: Prior DVT, extensive thrombus, no reversible provoking factor, positive D-dimer
• Option 2: Serial ultrasound surveillance at 1 and 2 weeks if anticoagulation withheld
  • Only if low bleeding risk and patient reliable for follow-up

Additional Management

• Discontinue oral estrogen permanently - contraindicated with VTE history 2
• Discuss alternative contraception: progestin-only methods acceptable
• Early ambulation encouraged unless severe symptoms 4
• Consider compression stockings for symptom relief (though not proven to prevent post-thrombotic syndrome)
• Patient education on anticoagulation, bleeding precautions, signs of PE

Follow-up

• If ultrasound negative but symptoms persist/worsen: Repeat ultrasound in 5-7 days 1
• If technically limited study: Repeat or consider CT/MR venography
• Hematology referral for anticoagulation management and discussion of extended therapy duration

Key pitfall to avoid: Do not rely on D-dimer when Wells score is ≥2 or clinical suspicion is high - this leads to false reassurance and missed diagnoses 1, 3. In this patient with prior DVT and multiple risk factors, proceed directly to imaging and strongly consider empiric anticoagulation while awaiting results 4.